ACCESSION: MSBNK-SMB_Measured-HSA033P0193004
RECORD_TITLE: Uncharacterized; LC-ESI-QTOF; MS2; NEGATIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.15, Processed 2025.02.15, Annotated 2025.04.01, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Liang et al. J Pharm Biomed Anal. 2022, 214, 114718
COMMENT: This is an averaged mass spectra data created by integrating product ion scan data obtained from the follwing DDA dataset.
COMMENT: DATASET_ID MTBLS3854
COMMENT: DATASET_TITLE Long-term low-dose ionizing radiation induced chromosome-aberration-specific metabolic phenotype changes in radiation workers
COMMENT: DATASET_AUTHORS Xinjun Wang
COMMENT: MS1_M/Z_AVERAGED_THRES 20.000
COMMENT: MS2_M/Z_AVERAGED_THRES 20.000
COMMENT: DATASET_FILE_NUM 50
COMMENT: NUM_AVERAGED_SPEC 12
COMMENT: RAW_SPEC {'D94neg_2605': {'bp': 2166.0, 'sum': 6022.0}, 'D74neg_2567': {'bp': 1849.0, 'sum': 5471.0}, 'D171neg_2679': {'bp': 1682.0, 'sum': 4491.0}, 'C4neg_2571': {'bp': 1192.0, 'sum': 3175.0}, 'D87neg_2676': {'bp': 1116.0, 'sum': 3678.0}, 'D102neg_2655': {'bp': 1072.0, 'sum': 3366.0}, 'C6neg_2634': {'bp': 1049.0, 'sum': 2752.0}, 'C16neg_2593': {'bp': 1020.0, 'sum': 3270.0}, 'C2neg_2653': {'bp': 875.0, 'sum': 2494.0}, 'C15neg_2616': {'bp': 622.0, 'sum': 2185.0}, 'D178neg_2587': {'bp': 528.0, 'sum': 1636.0}, 'C12neg_2582': {'bp': 327.0, 'sum': 973.0}}
COMMENT: RETENTION_TIME_STDEV 0.025
COMMENT: PRECURSOR_M/Z_RAW 193.013146
COMMENT: PRECURSOR_M/Z_STDEV 0.000837
COMMENT: PRECURSOR_IN_MS1 mz 193.013386; int 26.268; delta(ppm) -0.502888
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M-H; M+Cl; mz 228.990904; int 1.029; cor 0.834
COMMENT: PROPOSED_ION_FORM M+Cl; M-H; mz 157.037015; int 215.984; cor 0.811
COMMENT: PROPOSED_MAX_NUM_S 8
COMMENT: PROPOSED_MF SevenGoldenRules 11.756; C10H2N4O; [M-H]1; delta(ppm) -11.756485
COMMENT: PROPOSED_MF SevenGoldenRules 9.339; C10H10S2; [M-H]1; delta(ppm) -9.339215
COMMENT: PROPOSED_MF SevenGoldenRules 4.860; C9H6O5; [M-H]1; delta(ppm) -4.860309
COMMENT: PROPOSED_MF SevenGoldenRules 8.035; C13H6S; [M-H]1; delta(ppm) 8.035230
COMMENT: PROPOSED_MF SevenGoldenRules 11.391; C5H10N2O2S2; [M-H]1; delta(ppm) 11.390544
COMMENT: PROPOSED_MF SevenGoldenRules 0.557; C4H6N4O3; [M+Cl]1; delta(ppm) -0.556807
COMMENT: PROPOSED_MF SevenGoldenRules 15.704; C7H12P2; [M+Cl]1; delta(ppm) 15.704497
COMMENT: PROPOSED_MF MS-FINDER 3.904; C4H6N4O3; [M+Cl]-; delta(ppm) -110592.657441
COMMENT: PROPOSED_MF MS-FINDER 2.676; C9H6O5; [M-H]-; delta(ppm) -4.884974
COMMENT: PROPOSED_MF MS-FINDER 2.623; C5H10N2O2S2; [M-H]-; delta(ppm) 11.454544
COMMENT: PROPOSED_MF MS-FINDER 2.399; C3H7N4O4P; [M-H]-; delta(ppm) 0.469869
COMMENT: PROPOSED_MF MS-FINDER 2.032; C5H2N6O3; [M-H]-; delta(ppm) 9.027737
COMMENT: PROPOSED_MF MS-FINDER 1.916; C4H14O2S2; [M+Cl]-; delta(ppm) -110590.737762
COMMENT: PROPOSED_MF MS-FINDER 1.884; C4H6N2O7; [M-H]-; delta(ppm) 15.957039
COMMENT: PROPOSED_MF MS-FINDER 1.669; C10H2N4O; [M-H]-; delta(ppm) -11.813986
COMMENT: PROPOSED_MF MS-FINDER 1.595; C10H10S2; [M-H]-; delta(ppm) -9.387281
COMMENT: PROPOSED_MF MS-FINDER 1.526; C13H6S; [M-H]-; delta(ppm) 8.078475
COMMENT: PROPOSED_MF SIRIUS5_Sirius 17.643; C4H6N4O3; [M+Cl]-; delta(ppm) -110592.657441
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C4H6N4O3; [M+Cl]-; delta(ppm) -110592.657441
COMMENT: PROPOSED_MF SIRIUS6_Sirius 28.791; C4H7ClN4O3; [M-H]-; delta(ppm) -110592.657441
COMMENT: PROPOSED_MF SIRIUS6_Sirius 25.982; C3H7N4O4P; [M-H]-; delta(ppm) 0.469869
COMMENT: PROPOSED_MF SIRIUS6_Sirius 25.228; C4H6N4O3; [M+Cl]-; delta(ppm) -110592.657441
COMMENT: PROPOSED_MF SIRIUS6_Sirius 16.730; C5H2N6O3; [M-H]-; delta(ppm) 9.027737
COMMENT: PROPOSED_MF SIRIUS6_Sirius 16.091; C2H3FN6O4; [M-H]-; delta(ppm) 3.107587
COMMENT: PROPOSED_MF SIRIUS6_Sirius 14.526; C7H4N3O4; [M-H]-; delta(ppm) 2.071334
COMMENT: PROPOSED_MF SIRIUS6_Sirius 14.343; C2H6N6O3S; [M-H]-; delta(ppm) -8.438051
COMMENT: PROPOSED_MF SIRIUS6_Sirius 11.974; CH5N7O3P; [M-H]-; delta(ppm) 7.426251
COMMENT: PROPOSED_MF SIRIUS6_Sirius 11.590; C2H4N7O2; [M+Cl]-; delta(ppm) -110587.154637
COMMENT: PROPOSED_MF SIRIUS6_Sirius 9.975; CH7FN4O4; [M+Cl]-; delta(ppm) -110597.340468
COMMENT: PROPOSED_MF SIRIUS6_Sirius 9.727; C7H6BNO3S; [M-H]-; delta(ppm) 54720.028961
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.384; H9N5O3P; [M+Cl]-; delta(ppm) -110593.924267
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.500; C9H6O5; [M-H]-; delta(ppm) -4.884974
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.306; C5H9NO5P; [M-H]-; delta(ppm) -6.486415
COMMENT: PROPOSED_MF SIRIUS6_Sirius 2.644; C4H7F3NO2; [M+Cl]-; delta(ppm) -110588.138474
COMMENT: PROPOSED_MF SIRIUS6_Sirius 2.237; C6H8NO4; [M+Cl]-; delta(ppm) -110598.160178
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C4H6N4O3; [M+Cl]-; delta(ppm) -110592.657441
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C4H7ClN4O3; [M-H]-; delta(ppm) -110592.657441
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 1.000; POJWUDADGALRAB-UHFFFAOYSA-N; C4H6N4O3; ALLANTOIN
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.619; AAGSVSIRUBZUSD-UBTZLJEENA-N; [M-H]-; C\C(Cl)=C\C[C@@H](O)C(\C)=C\Cl
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.583; FDZZBIMAFOTVMT-UHFFFAOYSA-N; [M-H]-; O=C(N)C=1SC=2N=NC=CC2C1N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.556; NKNQLJMAPSUXLZ-UHFFFAOYSA-N; [M-H]-; O=C1NC(=O)C(=CC=2SC=CC2)N1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.515; XKTKHUXAWUXQOJ-UHFFFAOYSA-N; [M-H]-; NC1=C(OC=CC#N)C=CC(Cl)=C1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.286; AGLNTFQAHIRTFA-UHFFFAOYSA-N; [M-H]-; ClCC1=NN=C(O1)C=2C=CC=CC2
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.385; POJWUDADGALRAB-UHFFFAOYNA-N; [M+Cl]-; Allantoin
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.521; MLVVTNIFHMERMU-UHFFFAOYSA-N; [M+Cl]-; 1-(5-hydroxy-2-oxo-2,3-dihydroimidazol-4-yl)urea
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.200; NHZGRUILDDFUNP-UHFFFAOYSA-N; [M-H]-; pyrrolidin-1-yl N,N-bis(sulfanyl)carbamate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.134; NSDVPAHANCHBFV-UHFFFAOYSA-N; [M-H]-; 6,7,8-trihydroxy-2H-chromen-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.082; XALJYYXRQJOGCG-UHFFFAOYSA-N; [M-H]-; 5,6,7-trihydroxy-2H-chromen-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.030; OZNMEZAXFKUCPN-UHFFFAOYSA-N; [M-H]-; UNPD49272
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.030; XYKPFVCEJGWEPX-UHFFFAOYSA-N; [M-H]-; UNPD134569
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.978; CNTKQZXDAYRFBY-UHFFFAOYSA-N; [M-H]-; 4,7,8-trihydroxy-2H-chromen-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.978; FNYQCLTWIHHCQV-UHFFFAOYSA-N; [M-H]-; 4,6,7-trihydroxy-2H-chromen-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.978; HPNWGYCBCHLEMW-UHFFFAOYSA-N; [M-H]-; 4,5,7-trihydroxy-2H-chromen-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.978; VIIPQXJHKXQJKY-UHFFFAOYSA-N; [M-H]-; 2-(2H-1,3-benzodioxol-5-yl)-2-oxoacetic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.978; WVPYGTHKWYSUNM-UHFFFAOYSA-N; [M-H]-; 3-oxalobenzoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.978; LFLOMAIEONDOLV-UHFFFAOYSA-N; [M-H]-; 2-(carboxycarbonyl)benzoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.978; LUODACDZXGGDIL-UHFFFAOYSA-N; [M-H]-; 3,6,7-trihydroxy-2H-chromen-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.978; OJIYXYUCRVFSRV-UHFFFAOYSA-N; [M-H]-; 3,4,8-Trihydroxycoumarin
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; XALJYYXRQJOGCG-UHFFFAOYSA-N; [M-H]-; 5,6,7-trihydroxy-2H-chromen-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; NHZGRUILDDFUNP-UHFFFAOYSA-N; [M-H]-; pyrrolidin-1-yl N,N-bis(sulfanyl)carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; MLVVTNIFHMERMU-UHFFFAOYSA-N; [M+Cl]-; 1-(5-hydroxy-2-oxo-2,3-dihydroimidazol-4-yl)urea
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.983; NSDVPAHANCHBFV-UHFFFAOYSA-N; [M-H]-; 6,7,8-trihydroxy-2H-chromen-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.975; OZNMEZAXFKUCPN-UHFFFAOYSA-N; [M-H]-; UNPD49272
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.975; XYKPFVCEJGWEPX-UHFFFAOYSA-N; [M-H]-; UNPD134569
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.953; FNYQCLTWIHHCQV-UHFFFAOYSA-N; [M-H]-; 4,6,7-trihydroxy-2H-chromen-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.953; HPNWGYCBCHLEMW-UHFFFAOYSA-N; [M-H]-; 4,5,7-trihydroxy-2H-chromen-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.740; POJWUDADGALRAB-UHFFFAOYNA-N; [M+Cl]-; Allantoin
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.592; VIIPQXJHKXQJKY-UHFFFAOYSA-N; [M-H]-; 2-(2H-1,3-benzodioxol-5-yl)-2-oxoacetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.592; WVPYGTHKWYSUNM-UHFFFAOYSA-N; [M-H]-; 3-oxalobenzoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.592; LFLOMAIEONDOLV-UHFFFAOYSA-N; [M-H]-; 2-(carboxycarbonyl)benzoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.526; CNTKQZXDAYRFBY-UHFFFAOYSA-N; [M-H]-; 4,7,8-trihydroxy-2H-chromen-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.526; LUODACDZXGGDIL-UHFFFAOYSA-N; [M-H]-; 3,6,7-trihydroxy-2H-chromen-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.526; OJIYXYUCRVFSRV-UHFFFAOYSA-N; [M-H]-; 3,4,8-Trihydroxycoumarin
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.740; POJWUDADGALRAB-UHFFFAOYSA-N; [M+Cl]-; (2,5-dioxoimidazolidin-4-yl)urea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.521; LFLOMAIEONDOLV-UHFFFAOYSA-N; [M-H]-; 2-oxalobenzoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.000; JZAXSONNGUOWCS-UHFFFAOYSA-N; [M-H]-; 3-methyl-2-(3-methylthiophen-2-yl)thiophene
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.000; ZKQAFLPPDHWQCK-UHFFFAOYSA-N; [M-H]-; (1,1-dioxothiolan-3-yl)thiourea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.874; FZWZZYUAWYMFBS-UHFFFAOYSA-N; [M-H]-; 6,8-dihydroxy-3H-cyclohepta[c]furan-1,5-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.585; HPNWGYCBCHLEMW-UHFFFAOYSA-N; [M-H]-; 4,5,7-trihydroxychromen-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.425; DHHVHVIUTWJSFR-OWOJBTEDSA-N; [M-H]-; 6-oxo-5-[(E)-3-oxoprop-1-enyl]pyran-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.425; IQBFGXJTTIFUFR-OWOJBTEDSA-N; [M-H]-; 6-oxo-4-[(E)-3-oxoprop-1-enyl]pyran-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.278; OMWWLAWOSZODOO-UHFFFAOYSA-N; [M-H]-; 5-hydroxy-5H-furo[3,4-f][1,3]benzodioxol-7-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.111; JFEONFYENHQOBL-UHFFFAOYSA-N; [M+Cl]-; 2-(4-nitrotriazol-2-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.000; BJSXXQGVZDMVEM-UHFFFAOYSA-N; [M-H]-; 2-(cyclopropylsulfamoyl)ethanethioamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.857; PNODFDYINILVKZ-UHFFFAOYSA-N; [M-H]-; 4-formylphthalic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.841; CEPNDKRJQPJVNM-UHFFFAOYSA-N; [M-H]-; 2,4-dihydroxybenzene-1,3,5-tricarbaldehyde
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -12.904; POJWUDADGALRAB; [M+Cl]-; Allantoi
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -117.205; MLVVTNIFHMERMU; [M+Cl]-; allantoin, enol-form
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -316.841; MCSNAXPUEZZHNA; [M+Cl]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.459; POJWUDADGALRAB; [M+Cl]-; Allantoi
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -3.318; POJWUDADGALRAB; [M+Cl]-; Allantoin
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -75.012; MLVVTNIFHMERMU; [M+Cl]-; 1-(5-Hydroxy-2-oxo-2,3-dihydroimidazol-4-yl)urea
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -123.361; SZFCYOOEOMZUHL; [M-H]-; 3-(Carbamoylamino)-1-(2-chloroacetyl)urea
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -217.536; MCSNAXPUEZZHNA; [M+Cl]-; 3-Methyl-4-furoxancarbohydrazide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -368.050; FGIUDZGQIRZHBT; [M-H]-; Azido 2-amino-2-chloro-3-hydroxybutanoate
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.556; POJWUDADGALRAB; [M+Cl]-; Allantoin
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula Cl1C5H6N4O3; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(6), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Plasma
AC$INSTRUMENT: Agilent 1290 liquid chromatography system, Agilent Technologies - TripleTOF 6600+ mass spectrometer, AB SCIEX
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE NEGATIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 30 eV
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE -4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 20.00; MS2(ppm) 20.00
AC$CHROMATOGRAPHY: COLUMN_NAME ACQUITY UPLC BEH C18 column (1.7 Âµm, 2.1 mm x 100 mm; Waters)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 7.0 min: 65, 8.0 min: 40, 9.0 min: 40, 9.1 min: 95, 12.0 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.5 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 2.969
MS$FOCUSED_ION: PRECURSOR_M/Z 193.013304
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-01oy-9200000000-f642673074e96b289f5b
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  34.9697760 483.4148 34.969756 10.5520 107.63 1.0000 9 ?
  41.9987097 999.0000 41.998705 9.8098 135.59 0.9121 11 f{C1N1O1}/4.11ppm,p-Cl1C5H6N3O2
  97.0037949 975.7252 97.003746 6.4637 172.29 0.7950 11 f{C3H1N2O2}/-5.73ppm,p-Cl1C3H5N2O1
  114.0299260 624.7606 114.029884 7.6383 175.76 0.8982 11 f{C5H6O3}/-20.32ppm,p-Cl1C1N4
PK$NUM_PEAK: 4
PK$PEAK: m/z int. rel.int.
  34.969776 483.41 483
  41.998710 999.00 999
  97.003795 975.73 975
  114.029926 624.76 624
//
